Delivery Order SPE2DE24D0013-SPE2D625F77NR
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $3,456.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This...
- This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $4,539.30, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV),...
- This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, worth $13,600.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is part of...
- This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a delivery order worth $4,539.30 with a firm fixed price pricing type and an ultimate completion date of April 18, 2025. Cepheid, the prime contractor, will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, to support the detection of infectious diseases...
- This federal contract award, valued at $3,994.64, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has a firm fixed price pricing type. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
- This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,085.37 and is a firm fixed-price delivery order with no set-aside designation. The contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract has a ceiling value of...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract has a total ceiling value of $2,500.00 and an ultimate completion date of February 27, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Cepheid is the prime contractor and has...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F77NRDelivery Order
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $2,208.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting a variety of infectious diseases, including COVID-19, influenza, and sexually transmitted diseases. This contract is part of a larger Indefinite Delivery Vehicle (IDV) held by Cepheid, which enables the DLA and other federal agencies to continuously procure Cepheid's molecular diagnostic solutions. Cepheid has also been awarded federal grants as a subrecipient, collaborating with academic institutions and other organizations on specialized research projects related to diagnostic testing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/13/25 |